1. Charting Progress in MS Treatment:

2. Program Goals

3. Disclaimer

4. Principles of MS

5. MS Treatment Landscape

6. MS as an Immune-Mediated Disease

7. Factors Affecting Choice of DMTs

8. Factors Affecting Choice of DMTs (cont)

9. Case 1: Karen

11. Factors Suggesting Worse Prognosis

12. Treatment Options

13. First-Line Parenterals

14. Second-Line Parenterals

15. Oral Agents

16. Case 1: Treatment Considerations

17. Case 2: Scott

19. Case 2: Scott (cont)

20. Adherence

21. Case 2: Scott (cont)

22. Case 2: Scott (cont) - Follow-up MRI

23. Case 2: Scott (cont)

24. Case 3: Maria

26. Case 3: Maria (cont)

27. Considerations for Switching Therapy

28. Case 3: Maria (cont)

29. Estimated Risk of PML

30. Key Points

31. Abbreviations

32. References

33. References (cont)

34. References (cont)